Raj Shrivastava, MD
img_Raj Shrivastava
PROFESSOR | Neurosurgery
PROFESSOR | Otolaryngology
Are you a patient?
Specialties
Neurosurgery
Research Topics
Anatomy, Anti-Tumor Therapy, Bioinformatics, Brain, Brain Imaging, Clinical Genomics, Computer Simulation, Genomics, MRI, Neural Networks, Neuroscience, Pituitary, Robotic Surgery, Systems Neuroscience, Translational Research
Endoscopic Skull Base Surgery
The Endoscopic Skull Base Surgery research group focuses on the clinical implementation of stereotactic and 3D navigation for minimally invasive skull base and pituitary tumor surgery. The team researches unique visual-evoked-potential (VEP) neuro-physiological monitoring to monitor visual pathways during neurosurgical tumor surgery to provide for improved clinical outcome.

Endoscopic Skull Base Surgery

Ultra-High Field MRI Tumor Mapping
The BioMedical Engineering and Imaging Institute (BMEII) research group has an NIH funded program that develops newer techniques to accurately map tumors and anatomy using ultra-high field 7T MRI. This will allow for more precise and targeted surgical resections-ultimately for better patient outcomes.

The BioMedical Engineering and Imaging Institute

BS, MS, Stanford University

MD, University of Pennsylvania

Internship, Surgery (General Surgery), Mount Sinai Hospital

Residency, Neurosurgery, Mount Sinai Hospital

Fellowship, Neurosurgery, St. Luke's-Roosevelt Hospital Center

Certifications

American Board of Neurological Surgery

2019, 2023

Cullman Family Award

Mount Sinai Health System

2017, 2019, 2020

New York Magazine Best Doctors

2015-2019

America's Top Surgeon Award

2013-2019

Castle Connolly Top Doctors

Castle Connolly

2012-2019

US News and World Report Selected Top Doctor-Neurosurgery

2011-2019

Patient's Choice Award - National Award

2011-2019

Compassionate Physician Award - National Award

Patient's Choice - Vital Health Care Group

2001

American Association of Neurosurgeons (AANS) Vesalius Award - First Presentation

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Shrivastava has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.